Major Japanese Drug Makers Focus On R&D To Restore Sagging Sales
This article was originally published in PharmAsia News
Executive Summary
Japan's four major drug makers are focusing their budgets on research and development for innovative drugs, all sacrificing short-term returns for medium-term gains